1. Miri-Aliabad G, Fadaee M, Khajeh A, Naderi M. Marital status and fertility in adult Iranian patients with β-thalassemia major. Indian J Hematol Blood Transfus 2016;32(1):110-3. doi:10.1007/s12288-015-0510-9
2. McGann PT, Nero AC, Ware RE. Clinical features of β-thalassemia and sickle cell disease. Adv Exp Med Biol 2017;1013:1-26. doi:10.1007/978-1-4939-7299-9_1
3. Miri-Aliabad G, Rezaeifar A, Salarzaei M. Comparison of immunoglobulins status in splenectomized and non-splenectomized patients with major β-thalassemia. J Pediatr Rev 2022;10(2):161-6. doi:10.32598/jpr.10.2.951.2
4. Yousefian S, Miri-Aliabad G, Saleh R, Khedmati M. Association of body mass index and serum ferritin level in pediatrics with β-thalassemia major disease. Iran J Pediatr Hematol Oncol 2022;12(1):34-40. doi:10.18502/ijpho.v12i1.8359
5. Miri-Aliabad G, Asgarzadeh L, Dorgalaleh A, Bahraini M. Prevalence of acute complications of transfusion in children with β-thalassemia major in southeast Iran: a prospective study. J Kerman Uni Med Sci 2023;30(4):229-32. doi:10.34172/ jkmu.2023.38
6. Miri-Aliabad G, Tabatabaei SM, Vaezi Z, Amini A, Asgarzadeh L. Causes of birth of more than one thalassemia major patient in families in south-east of Iran: lessons for prevention programs. Health Scope 2021;10(3): e116634. doi:10.5812/ jhealthscope.116634
7. Galanello R, Origa R. Beta-thalassemia. Orphanet J Rare Dis 2010;5:11. doi:10.1186/1750-1172-5-11
8. Amirabadi F, Saravani S, Miri-Aliabad G, Khorashadi-Zadeh M. The association between dental health status and oral health-related quality of life of children diagnosed with β-thalassemia major in Zahedan city, Iran. Int J Pediatr 2019;7(2):8985-91. doi:10.22038/ijp.2018.34517.3034
9. Ansari S, Azarkeivan A, Miri-Aliabad G, Yousefian S, Rostami T. Comparison of iron chelation effects of deferoxamine, deferasirox, and combination of deferoxamine and deferiprone on liver and cardiac T2* MRI in thalassemia major. Caspian J Intern Med 2017;8(3):159-64. doi:10.22088/cjim.8.3.159
10. Miri-Aliabad G, Naderi M, Izadi-Nia H. Burkitt leukemia in a child with β-thalassemia major. J Kerman Uni Med Sci 2022;29(1):91-4. doi:10.22062/jkmu.2022.91868
11. Borgna-Pignatti C, Gamberini MR. Complications of thalassemia major and their treatment. Expert Rev Hematol 2011;4(3):353- 66. doi:10.1586/ehm.11.29
12. Riaz M, Abbas M, Rasool G, Baig IS, Mahmood Z, Munir N, et al. Prevalence of transfusion-transmitted infections in multiple blood transfusion-dependent thalassemic patients in Asia: a systemic review. Int J Immunopathol Pharmacol 2022;36:3946320221096909. doi:10.1177/03946320221096909
13. Yasmeen H, Hasnain S. Epidemiology and risk factors of transfusion transmitted infections in thalassemia major: a multicenter study in Pakistan. Hematol Transfus Cell Ther 2019;41(4):316-23. doi:10.1016/j.htct.2019.03.008
14. Chattopadhyay S, Mukherjee R, Nandi A, Chakraborty PS, Rit K, Chaudhuri SJ. Prevalence of hepatitis B&C in thalassemia patients in a tertiary care hospital in West Bengal. IOSR J Dent Med Sci 2014;13(7):68-70.
15. Waheed U, Saba N, Wazeer A, Ahmed S. A systematic review and meta-analysis on the epidemiology of hepatitis B and hepatitis C virus among β-thalassemia major patients in Pakistan. J Lab Physicians 2021;13(3):270-6.
doi:10.1055/s-0041-1731110
16. Ehsan H, Wahab A, Anwer F, Iftikhar R, Yousaf MN. Prevalence of transfusion transmissible infections in β-thalassemia major patients in Pakistan: a systematic review. Cureus 2020;12(8): e10070. doi:10.7759/cureus.10070
17. Akhtar S, Abdul Nasir J, Hinde A. The prevalence of hepatitis C virus infection in β-thalassemia patients in Pakistan: a systematic review and meta-analysis. BMC Public Health 2020;20(1):587. doi:10.1186/s12889-020-8414-5
18. Bhuyan GS, Noor AU, Sultana R, Noor FA, Sultana N, Sarker SK, et al. Frequency of hepatitis B, C and HIV infections among transfusion-dependent β-thalassemia patients in Dhaka. Infect Dis Rep 2021;13(1):89-95. doi:10.3390/idr13010011
19. Miri-Aliabad G. Beta-thalassemia: an overview of epidemiology, clinical features, diagnosis, and management. Avicenna J Clin Med 2025;31(4):255-63. doi:10.32592/ajcm.31.4.255